Harvard Bioscience, Inc. (HBIO): Price and Financial Metrics

HBIO POWR Grades

• Value is the dimension where HBIO ranks best; there it ranks ahead of 82.77% of US stocks.
• The strongest trend for HBIO is in Stability, which has been heading up over the past 179 days.
• HBIO ranks lowest in Momentum; there it ranks in the 19th percentile.

HBIO Stock Summary

• With a one year PEG ratio of 565.76, Harvard Bioscience Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 94.92% of US stocks.
• The price/operating cash flow metric for Harvard Bioscience Inc is higher than 97.7% of stocks in our set with a positive cash flow.
• In terms of twelve month growth in earnings before interest and taxes, Harvard Bioscience Inc is reporting a growth rate of -156.89%; that's higher than merely 12.14% of US stocks.
• Stocks that are quantitatively similar to HBIO, based on their financial statements, market capitalization, and price volatility, are VERX, GLBE, CSPI, REFR, and MYGN.
• Visit HBIO's SEC page to see the company's official filings. To visit the company's web site, go to www.harvardbioscience.com.

HBIO Valuation Summary

• In comparison to the median Healthcare stock, HBIO's price/sales ratio is 73.57% lower, now standing at 3.
• HBIO's EV/EBIT ratio has moved down 1985.8 over the prior 243 months.
• Over the past 243 months, HBIO's price/sales ratio has gone down 8.7.

Below are key valuation metrics over time for HBIO.

HBIO Growth Metrics

Its 4 year price growth rate is now at -11.78%.
• Its year over year cash and equivalents growth rate is now at -1.14%.
• The year over year revenue growth rate now stands at -5.75%.

Over the past 15 months, HBIO's revenue has gone up $16,816,000.

The table below shows HBIO's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	118.904	1.262	-0.288
2021-09-30	116.833	3.635	-1.864
2021-06-30	111.207	5.892	-2.792
2021-03-31	105.318	7.497	-3.963
2020-12-31	102.1	9.331	-7.81
2020-12-31	102.1	9.331	-7.81

HBIO's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• HBIO has a Quality Grade of C, ranking ahead of 42.11% of graded US stocks.
• HBIO's asset turnover comes in at 0.728 -- ranking 27th of 75 Measuring and Control Equipment stocks.
• CAMT, NVMI, and ITRI are the stocks whose asset turnover ratios are most correlated with HBIO.

The table below shows HBIO's key quality metrics over time.